Recombinant CD22 (Epratuzumab Biosimilar) 抗体
The Humanized 单克隆 anti-CD22 (Epratuzumab Biosimilar) antibody (ABIN7795108) specifically detects CD22 (Epratuzumab Biosimilar) in FACS 和 in vivo.
The antibody is reactive with 人 samples.
产品编号 ABIN7795108
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CD22 (Epratuzumab Biosimilar) 抗体 (ABIN7795108)
抗原
CD22 (Epratuzumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
单克隆
标记
This CD22 (Epratuzumab Biosimilar) antibody is un-conjugated
应用范围
Flow Cytometry (FACS), In vivo Studies (in vivo)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Epratuzumab Biosimilar, Endotoxin 0.05 EU/mg
-
产品特性
- Epratuzumab Biosimilar uses the same protein sequences as the therapeutic antibody epratuzumab. Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus. Epratuzumab is a recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells. It binds with high specificity to normal B-cells and B-cell tumors at the third Ig-like domain of CD22. After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC).
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- Less than 0.5 EU/mg of protein as determined by LAL method
-
免疫原
- Human CD22
-
-
anti-CD22 (Epratuzumab Biosimilar) antibody
适用: 人, Cynomolgus, 猕猴 FACS, BP, IP 宿主: 兔 Chimeric hL22 unconjugated Recombinant Antibody
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- CD22 (Epratuzumab Biosimilar)
-
别名
- Epratuzumab Biosimilar
-
物质类
- Biosimilar
抗原
-
You are here:
